Clinical trial

The Effects of LY2409021 on the Liver

NCT01588366

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE1

Study timeline

Study start (unknown)2012-04-01Date precision: month

Registry last updated2019-03-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

PlaceboDRUG

LY2409021DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01588366 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.